Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
Ryan B. Perumpail

, Robert J. Wong, Andy Liu, Channa R. Jayasekera, Douglas T. Dieterich, Zobair M. Younossi, and Aijaz Ahmed
Author affiliations: Stanford University School of Medicine, Stanford, California, USA (R.B. Perumpail, A. Ahmed); Highland Hospital, Oakland, California, USA (R.J. Wong); Albert Einstein School of Medicine, Bronx, New York, USA (A. Liu); California Pacific Medical Center, San Francisco, California, USA (C.R. Jayasekera); Icahn School of Medicine at Mount Sinai, New York, New York, USA (D.T. Dieterich); Inova Fairfax Hospital Center for Liver Diseases, Falls Church, Virginia, USA (Z.M. Younossi); Inova Health System Betty and Guy Beatty Center for Integrated Research, Falls Church (Z.M. Younossi)
Main Article
Table
Liver transplant waitlist additions and liver transplant recipients, United States*
Liver transplant recipients |
Birth cohort total |
1,677 (48.9) |
2,926 (63.7) |
4,324 (71.2) |
4,475 (78.1) |
HCV |
598 (17.4) |
1,416 (30.8) |
2,004 (33.0) |
2,029 (35.4) |
Non-HCV |
1,079 (31.5) |
1,510 (32.9) |
2,320 (38.2) |
2,446 (42.7) |
Non–birth cohort total |
1,751 (51.1) |
1,667 (36.3) |
1,747 (28.8) |
1,256 (21.9) |
HCV |
396 (11.6) |
393 (8.6) |
309 (5.1) |
208 (3.6) |
Non-HCV |
1,355 (39.5) |
1,274 (27.7) |
1,438 (23.7) |
1,048 (18.3) |
Total |
3,428 (100.0) |
4,593 (100.0) |
6,071 (100.0) |
5,731 (100.0) |
Main Article
Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.